GSK GlaxoSmithKline PLC

  • STOCK
  • GSK
  • Price as of: Feb 10, 01:28 PM EST
  • $39.32
  • -$0.02
  • -0.1%
  • Industry
  • Drug manufacturers - major
Share

GSK Stock Dividend Data

Add GSK to Watchlist
  • Dividend Yield
    6.81% Healthcare Average 1.78%
  • Annual Payout
    $2.68 Paid Quarterly
  • Payout Ratio
    98.8% EPS $2.71
  • Dividend Growth
    3 yrs Since 2013
  • Get GSK DARS™ Rating
Upcoming Dividend Payouts

GSK Upcoming Dividend Payouts

Next Ex-Dividend Date
Feb 17
Date
$0.58
Amount
Dividend Shot Clock®
Feb 17, 2016
Feb 17, 2016
Date has passed
Next Ex-Dividend Date
Next Pay Date
Amount Declare Date Ex-Dividend Date ▲ Record Date Pay Date Payout Type
$0.5822 2016-02-17 2016-02-19 2016-04-14 Special
$0.6695 2016-02-17 2016-02-19 2016-04-14 Regular
DARS Rating™ Breakdown

Dividend.com DARS Rating™ Breakdown for GSK

Sign Up
Metric GSK Rank GSK Avg Ranking Notes
Relative Strength Sign Up For Ticker Ranking Sign Up For Sector Ranking 1 year return is at par with Benchmark/Peers/Broader Market/Analyst Expectations
Overall Yield Attractiveness Sign Up For Ticker Ranking Sign Up For Sector Ranking Yield is better than Benchmark/Peers/Broader Market/Analyst Expectations
Dividend Reliability Sign Up For Ticker Ranking Sign Up For Sector Ranking Payout ratio is considerably higher than industry average and peers
Dividend Uptrend Sign Up For Ticker Ranking Sign Up For Sector Ranking Dividends are above average, growing as per Benchmark/Peers/Broader Market/Analyst Expectations
Earnings Growth Sign Up For Ticker Ranking Sign Up For Sector Ranking EPS growth is at par with Benchmark/Peers/Broader Market/Analyst Expectations
DARS Rating Sign Up For Ticker Ranking Sign Up For Sector Ranking Sign Up For DARS Ratings
Growth History

GSK Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2012
Consecutive
Years of
Increases
Reveal More Dividend Growth History for GSK 2.5% -7.3% 3 years
Reveal More Dividend Growth History for GSK
Historical Annual Dividend Data & Growth

GSK Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
$2.4613 2015 -7.3%
$2.6539 2014 11.9%
Historical Dividend Data

GSK Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$0.6695 2016-02-17 2016-02-19 2016-04-14 Unknown Regular Quarter
$0.5822 2016-02-17 2016-02-19 2016-04-14 Unknown Special N/A
$0.5440 2015-11-10 2015-11-13 2016-01-14 Unknown Regular Quarter
$0.5719 2015-08-12 2015-08-14 2015-10-01 Unknown Regular Quarter
$0.5812 2015-05-13 2015-05-15 2015-07-09 Unknown Regular Quarter
$0.6952 2015-02-18 2015-02-20 2015-04-09 Unknown Regular Quarter
$0.6130 2014-11-05 2014-11-07 2015-01-08 Unknown Regular Quarter
$0.6482 2014-08-06 2014-08-08 2014-10-02 Unknown Regular Quarter
$0.6400 2014-05-14 2014-05-16 2014-07-10 Unknown Regular Quarter
$0.7496 2014-02-19 2014-02-21 2014-04-10 Unknown Regular Quarter
$0.6161 2013-11-13 2013-11-15 2014-01-09 Unknown Regular Quarter
$0.5532 2013-08-07 2013-08-09 2013-10-03 Unknown Regular Quarter
$0.5502 2013-05-08 2013-05-10 2013-07-11 Unknown Regular Quarter
$0.6895 2013-02-20 2013-02-22 2013-04-11 Unknown Regular Quarter
$0.5790 2012-11-14 2012-11-16 2013-01-03 Unknown Regular Quarter
$0.5279 2012-08-08 2012-08-10 2012-10-04 Unknown Regular Quarter
$0.5491 2012-05-09 2012-05-11 2012-07-05 Unknown Regular Quarter
$0.6634 2012-02-15 2012-02-17 2012-04-12 Unknown Regular Quarter
$0.1580 2012-02-15 2012-02-17 2012-04-12 Unknown Special N/A
$0.5430 2011-11-02 2011-11-04 2012-01-05 Unknown Regular Quarter
$0.5211 2011-08-03 2011-08-05 2011-10-06 Unknown Regular Quarter
$0.5263 2011-05-04 2011-05-06 2011-07-07 Unknown Regular Quarter
$0.6153 2011-02-09 2011-02-11 2011-04-07 Unknown Regular Quarter
$0.5074 2010-10-27 2010-10-29 2011-01-06 Unknown Regular Quarter
$0.4573 2010-07-28 2010-07-30 2010-10-07 Unknown Regular Quarter
$0.4603 2010-05-05 2010-05-07 2010-07-08 Unknown Regular Quarter
$0.5737 2010-02-10 2010-02-12 2010-04-08 Unknown Regular Quarter
$0.4900 2009-11-04 2009-11-06 2010-01-07 Unknown Regular Quarter
$0.4609 2009-07-29 2009-07-31 2009-10-08 Unknown Regular Quarter
$0.4093 2009-04-29 2009-05-01 2009-07-09 Unknown Regular Quarter
$0.4946 2009-02-11 2009-02-13 2009-04-09 Unknown Regular Quarter
$0.4748 2008-10-29 2008-10-31 2009-01-08 Unknown Regular Quarter
$0.5191 2008-07-30 2008-08-01 2008-10-09 Unknown Regular Quarter
$0.5186 2008-04-30 2008-05-02 2008-07-10 Unknown Regular Quarter
$0.6273 2008-02-13 2008-02-15 2008-04-10 Unknown Regular Quarter
$0.5326 2007-10-31 2007-11-02 2008-01-10 Unknown Regular Quarter
$0.4947 2007-08-01 2007-08-03 2007-10-11 Unknown Regular Quarter
$0.4807 2007-05-02 2007-05-04 2007-07-12 Unknown Regular Quarter
$0.5516 2007-02-14 2007-02-16 2007-04-12 Unknown Regular Quarter
$0.4505 2006-11-01 2006-11-03 2007-01-04 Unknown Regular Quarter
$0.4063 2006-08-02 2006-08-04 2006-10-05 Unknown Regular Quarter
$0.3932 2006-05-10 2006-05-12 2006-07-06 Unknown Regular Quarter
$0.4875 2006-02-15 2006-02-17 2006-04-06 Unknown Regular Quarter
$0.3552 2005-11-02 2005-11-04 2006-01-05 Unknown Regular Quarter
$0.3478 2005-08-03 2005-08-05 2005-10-06 Unknown Regular Quarter
$0.3801 2005-05-11 2005-05-13 2005-07-07 Unknown Regular Quarter
$0.4444 2005-02-16 2005-02-18 2005-04-07 Unknown Regular Quarter
$0.3652 2004-11-03 2004-11-05 2005-01-06 Unknown Regular Quarter
$0.3659 2004-08-04 2004-08-06 2004-09-30 Unknown Regular Quarter
$0.3528 2004-05-12 2004-05-14 2004-07-01 Unknown Regular Quarter
$0.5199 2004-02-18 2004-02-20 2004-04-15 Unknown Regular Quarter
$0.3002 2003-10-29 2003-10-31 2004-01-06 Unknown Regular Quarter
$0.2864 2003-07-30 2003-08-01 2003-10-02 Yes Regular Quarter
$0.2851 2003-05-07 2003-05-09 2003-07-03 Yes Regular Quarter
$0.4187 2003-02-19 2003-02-21 2003-04-17 Yes Regular Quarter
$0.2772 2002-10-30 2002-11-01 2003-01-03 Yes Regular Quarter
$0.2803 2002-07-31 2002-08-02 2002-10-03 Unknown Regular Quarter
$0.2596 2002-05-01 2002-05-03 2002-07-05 Unknown Regular Quarter
$0.3423 2002-02-20 2002-02-22 2002-04-18 Unknown Regular Quarter
$0.2558 2001-10-31 2001-11-02 2002-01-03 Unknown Regular Quarter
$0.2546 2001-08-01 2001-08-03 2001-10-04 Unknown Unknown unknown
$0.2586 2001-05-02 2001-05-04 2001-07-05 Unknown Unknown unknown
Company Profile

GSK Company Profile

Exchange: NYSE
Sector: Healthcare

GlaxoSmithKline (GSK) is a global healthcare group. The company focuses on the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK was founded in 1999, and is based in the UK. In April 2014, GSK sold its cancer-drug business to Novartis for $14.5 billion and acquired Novartis’s vaccines business for $7.1 billion, along with creating a new consumer health business by operating a joint venture. GSK operates in a highly competitive business, and relies on patent protection and market exclusivity for its products to achieve high levels of profitability. GSK’s success is also dependent on its ability to continuously develop new pharmaceutical products. GSK has been paying a dividend since 2001 and has been increasing it consistently since 2009, which is when it last cut its payout. GSK pays its dividends quarterly.

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks
News

GlaxoSmithKline PLC News

  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check out Everything Investors Need to Know About...

  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check out Everything Investors Need to Know About...

  • Before today’s opening bell, a number of big-name dividend stocks were the subject of analyst moves. Below we highlight the most important analyst commentary for investors.

  • One of the biggest misconceptions in investing is that domestic markets are somehow safer and better than investing abroad. For whatever reason, many of us believe that owning stocks and bonds in the U.S. is the best way to go. As a result, this...

  • On this instalment of Dispatch we discuss the rough start to 2016, stocks to weather the storm, smart investment strategies and a story of greed that will change the way you look at copper wire.

  • The analysts here at Dividend.com analyzed the search patterns of visitors to our site during the past week ending January 8, 2016. Below, we give an analysis of how intelligently users used Dividend.com to help them in their investment...

  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...
  • Here at Dividend.com, we constantly emphasize the importance of strong fundamentals when it comes to making any investment decision. However, with...
  • Following news that UK-based GlaxoSmithKline plc () bribed doctors and officials to improve sales in China, the drugmaker announced that it...
  • GlaxoSmithKline to Sell Thrombosis Brands for $1.13B (GSK)

    GlaxoSmithKline plc (GSK) announced on Monday that it has agreed to sell its thrombosis drugs, Arixtra and Fraxiparine, and its Notre-Dame de Bondeville manufacturing facility for $1.13 billion. The British pharmaceutical company will sell both drug brands along with its manufacturing facility to The Aspen Group for £700 million or $1.13 billion in cash. This sale will allow GSK to focus on products with higher growth potential. GSK Chief Strategy Officer David Redfern commented: "Arixtra and Fraxiparine are established products that have consistently delivered strong revenues. However, our focus is on delivering an unprecedented late-stage pipeline and preparing for the launch of approved medicines. Aspen is a long-term partner of GSK and will be able to dedicate the resources that these products deserve to take them forward." GlaxoSmithKline shares were mostly flat during pre-market trading Monday. The stock is up 16% YTD.

    The Bottom Line

    Shares of GlaxoSmithKline plc (GSK) have a 4.38% yield based on Friday's closing price of $50.48. GlaxoSmithKline plc (GSK) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story